Holifya is a Milan-based digital clinic, launched in 2023, focused on the pharmacologic treatment of obesity and metabolic syndrome. Its AI-driven Patient Support Program integrates up to 3,000 biomarkers per patient (genetic, blood chemistry and anamnestic) with behavioural and clinical data to help physicians predict adverse effects, titrate dosing and automate follow-up, alongside a multidisciplinary team of specialist physicians, nutritionists, nurses and coaches. Co-founded and led by CEO Alessandra Cestaro, the company reports more than 3,000 patients treated.
1
Round
1
Industry
5
Tags
Sep 1, 2026
Latest raise
Funding activity · 1 round
Sep 1, 2026
EUR 1.6M
Seed
Led by CDP Venture Capital's Next Age program
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
